HOME >> BIOLOGY >> NEWS
Pneumococcal vaccine reduces ear infections, pneumonia, new study shows

VANDERBILT The pneumococcal conjugate vaccine, which has been routinely given to young children since 2000, reduces the incidence of middle ear infection and pneumonia, a new study shows.

"This highlights that the vaccine significantly decreases illnesses in children and reinforces its importance in our public health efforts," said Dr. Kathy Poehling, assistant professor of Pediatrics at Vanderbilt University Medical Center and Vanderbilt Children's Hospital in Nashville.

The study appears in the September issue of the journal "Pediatrics."

The pneumococcal conjugate vaccine is well known to control bacterial meningitis and bacteremia -- a bacterial infection in the blood system -- but doctors needed good evidence that it helped control other illnesses.

Ear infections (otitis media) and pneumonia are common infections in children; there are more than seven million cases of ear infection and more than one half million cases of pneumonia each year.

Poehling and colleagues studied data from Tennessee's Medicaid records and from three commercial insurance companies in upstate New York. They found that after routine vaccination with the pneumococcal conjugate vaccine began children in Tennessee younger than 2 years old had 7 percent fewer cases of otitis media in Tennessee; 20 percent of these children New York got ear infections.

Likewise, there were 17 percent fewer cases of pneumonia in Tennessee and 30 percent fewer cases in New York. These translate to about 10 fewer doctor visits, per 100 children, in Tennessee for ear infections and 40 fewer in New York; there were two fewer visits, per 100, for pneumonia in Tennessee and four fewer in New York.

"The cost control implications -- reducing emergency department and outpatient visits -- are also very important," Poehling said.

The study provides "the first data that demonstrate a decline in all pneumococcal-related diseases, not just invasive disease, in children aged
'"/>

Contact: Clinton Colmenares
clinton.colmenares@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
7-Sep-2004


Page: 1 2

Related biology news :

1. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
2. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
3. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
4. Protective gene may enhance vaccine responses
5. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
6. New glycan arrays discover autoimmunogenic activities of SARS-CoV: concern over monkey vaccine
7. Growing new breed of vaccine-producing plants to fight human diseases worldwide
8. Childrens Hospital Boston receives more than $10 million to help make smallpox vaccine safer
9. Triple-vaccine strategy stimulates strong HIV-specific immune response in monkeys
10. Herpes tool allows researchers to customize Alzheimers vaccine
11. Inadequate vaccines can help breed more vicious malaria strains

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/25/2019)... (PRWEB) , ... March 25, 2019 , ... ... and Visikol, a contract research organisation focused on advancing drug discovery, have announced ... 3D imaging. , Tissue clearing methods, which are essential to get a better ...
(Date:3/23/2019)... ... March 22, 2019 , ... SeqOnce Biosciences Inc. launches ... preparation. RhinoSeq employs a proprietary kit chemistry that makes it the fastest DNA ... preformatted master mixes for a simple, fast, and stable workflow. The 12-minute library ...
(Date:3/18/2019)... ... March 18, 2019 , ... Periodontal disease, where bacterial infection ... nearly 50% of the US population. Making this disease particularly challenging to treat ... where the cells are enmeshed in a sticky extracellular material that makes them more ...
Breaking Biology News(10 mins):
(Date:4/16/2019)... FREDERICK, Md. (PRWEB) , ... April 16, 2019 ... ... will honor Blue Sources and their project partner, the U.S. Army Center for ... Retransfer of Aquatic Biomonitor Through Combined In-Licensing/Out-Licensing.” , Blue Sources, a veteran-owned company ...
(Date:4/10/2019)... DIEGO (PRWEB) , ... April 10, 2019 , ... After ... kitchen upgrade. The new kitchen is equipped with updated appliances and modern lighting ... company’s La Jolla-based venue. , “We’ve seen tremendous growth in the demand ...
(Date:4/8/2019)... ... ... US Capital Global Securities , an affiliate of US Capital Global, is ... pharmaceutical company, S1 Biopharma (“S1”). , S1 has a pipeline of drugs targeted at ... and is ready to begin phase 2b trials. In phase 2a trials, Lorexys had ...
(Date:3/27/2019)... ... March 26, 2019 , ... A leader in the ... services to veterinarians across the United States and Canada since 2004. The primary ... soft tissue injuries in the dog, cat, and horse. Recently, VetStem teamed ...
Breaking Biology Technology:
Cached News: